This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hemorrhagic Stroke
and you are
between 18 and 80
years old
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

Astragalus membranaceus (AM) is used to treat stroke for a long time, and a number of studies have shown that AM can reduce cerebral infarction area and has anti-oxidation activity. PG2, a sterile powder of polysaccharides isolated from the root of astragulus (Huang-Chi) for intravenous injection, has been approved as a botanical drug by TFDA. Hemorrhagic stroke will induce secondary peri-blood clot edema and that may increase intracranial pressure to exacerbate clinical symptom. Therefore, the purpose of the present study was to investigate the efficacy of PG2 on hemorrhagic stroke.

Provided treatments

  • Drug: PG2
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01325233. The sponsor of the trial is PhytoHealth Corporation and it is looking for 61 volunteers for the current phase.
Official trial title:
The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke